Files

Download

Download Full Text (1.4 MB)

Division

West Florida

Hospital

Bayonet Point

Specialty

Endocrinology

Document Type

Poster

Publication Date

5-2020

Keywords

Osteoporosis; Fracture; Teriparatide; Healing

Disciplines

Endocrinology, Diabetes, and Metabolism | Musculoskeletal Diseases | Nutritional and Metabolic Diseases | Rheumatology

Abstract

Teriparatide, a parathyroid hormone analog, is an important anabolic agent approved by the U.S. Food and Drug Administration to increase bone mineral density in osteoporotic patients. Parathyroid hormone (PTH) regulates calcium, phosphate, and active vitamin-D metabolites. The amino terminal peptide fragments of PTH has been known to increase bone mass and are being used in clinical practice for osteoporosis management.3 Teriparatide increases bone density of lumbar spine and femoral neck, and decreases the risk of vertebral and non-vertebral fractures both in postmenopausal women and men. It is also known to prevent fractures in patients with osteoporosis and promote healing of fractures.

Teriparatide and its Bone Healing Power

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.